Navigation Links
Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics' BioZ(R) ICG Technology
Date:8/19/2007

Positive Local Coverage Changes Affect Region with Higher Incidence of

Hypertension in United States

SAN DIEGO, Aug. 7 /PRNewswire-FirstCall/ -- CardioDynamics (Nasdaq: CDIC), the innovator and leader of BioZ(R) impedance cardiography (ICG) technology, today announced that two contractors for the Centers for Medicare and Medicaid Services (CMS) recently made changes to their coverage policies that allowed expanded coverage of ICG for patients with high blood pressure, also referred to as hypertension. The involved local contractors provide coverage for patients in Mississippi, Alabama, Georgia and South Carolina. These states are known for having higher rates of hypertension in the United States and have struggled to find innovative means of treating and controlling hypertensive patients. The new local coverage allows treatment for resistant hypertension (uncontrolled blood pressure on three or more drugs) and complements the currently covered national indications, including heart failure, shortness of breath, and pacemaker optimization.

The changes in local coverage allowing ICG hypertension coverage occurred after a November 2006 CMS decision not to expand ICG hypertension coverage to a national indication. The Company believes the CONTROL Trial, along with evidence from 22 additional studies including over 2,300 subjects, were major factors for the expanded local coverage. Favorable clinical evidence was published in 2006 from the multi-center CONTROL trial, which demonstrated that use of BioZ(R) ICG led to an 8 mm Hg greater systolic blood pressure reduction and 7 mm Hg greater diastolic blood pressure reduction than standard care. Patients being treated with BioZ(R)-assisted therapy were 35% more likely to reach goal blood pressure of less than 140/90 mm Hg and more than two times as likely to achieve a more aggressive blood pressure control of less than 130/85 mm Hg. The CONTROL trial was the second randomized contro
'/>"/>

SOURCE CardioDynamics

Copyright©2007 PR Newswire.

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. New Position Statement from The North American Menopause Society Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in Postmenopausal Women
2. Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse
3. PromegaExpress Expands Easy Access to Products with New Cabinet
4. Othera Pharmaceuticals Announces Upcoming Presentation Based Upon Expanded Understanding of Lead Compound Mechanism of Action
5. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
6. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
7. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
8. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
9. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
10. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
11. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... SHENYANG, CHINA , May 24, 2013 /PRNewswire/ ... ("3SBio" or the "Company"), a leading ... developing, manufacturing and marketing biopharmaceutical products, announced today ... (the "EGM"), the Company,s shareholders voted in favor ... previously announced agreement and plan of merger dated ...
(Date:5/23/2013)... Amgen (NASDAQ: AMGN ) will present ... on Thursday, May 30, 2013, at the Westin Boston Waterfront ... Eastern Daylight Time. Arvind Sood , vice ... conference. Live audio of the presentation can be accessed from ... Investors. A replay of the webcast will also be available ...
(Date:5/23/2013)...  MGC Diagnostics Corporation (NASDAQ: MGCD ) ... scheduled a conference call to discuss its financial results ... April 30, 2013. The call will be at 4:30 ... will report financial results for the second quarter of ... May 30, 2013. (Logo: http://photos.prnewswire.com/prnh/20120821/LA60189LOGO ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2
... to FDA for Stand-Alone Therapy in Q1 2008, ... AMLN ) and Eli Lilly and Company (NYSE: ... patients with type 2 diabetes who were,unable to achieve ... with either monotherapy (stand-alone) BYETTA(R) (exenatide),injection taken twice daily ...
... - "ADVANCE Results go Beyond Existing Evidence", ... study of diabetes treatments,show that intensive blood glucose ... as required, protects patients against serious,complications of the ... kidney disease by one-fifth. Presented today at the ...
Cached Medicine Technology:Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 2Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 3Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 4Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 5Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 6Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 7The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications 2
(Date:5/24/2013)... (PRWEB) May 24, 2013 With Memorial Day ... Amica Insurance is offering tips to help prevent ... National Fire Protection Association (NFPA) reports that gas grills ... and 2010. Charcoal or other solid-fueled grills, meanwhile, caused approximately ... As a result, Amica Insurance is sharing the following tips ...
(Date:5/24/2013)... 2013 Gift Card Network members ... in sustainable card material, are combining forces to ... as a sustainable gift card substrate. , The ... challenges and increase education and usage of these ... the reduction of carbon footprint and environmental impact ...
(Date:5/24/2013)... 2013 Area homeowners dreaming about owning a ... tubs to choose from at factory-direct pricing during the ... event takes place at Emerald Pool and Patio ... Jacuzzi, the industry's leading hot tub brand, scheduled the event ... The event will feature popular hot tub models at up ...
(Date:5/24/2013)... May 24, 2013 Dwell Media ... Brandon Huff as Executive Vice President of Digital for ... units, which represented a large portion of Yahoo's global ... as Dwell develops a fully-integrated commerce unit to launch ... experience monetizing digital content for leading firms in Silicon ...
(Date:5/24/2013)... 6Webs.com has educated thousands of buyers on ... security monitoring provider. The easy to read reviews ... consumers prefer for unbiased and impartial home security reviews. ... leading wireless home security system providers in the nation. ... number of key factors including reliability, technology and equipment. ...
Breaking Medicine News(10 mins):Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2Health News:2013 Best Wireless Security System Providers Reported by 6Webs.com 2
... one side of their visual field benefit from presentation ... sounds for an hour, their visual detection of light ... improved significantly. Neural pathways that simultaneously process information from ... embarked on a whole new therapy approach" says PD ...
... , TUESDAY, May 29 (HealthDay News) -- If you want ... laughing, say researchers who have found that centenarians are often ... perspective. The findings stem from the Longevity Genes Project, ... York City. All the participants in the latest study were ...
... May 30 (HealthDay News) -- Even after they shed their ... "anti-fat prejudice," according to a new study. Researchers asked ... either lost 70 pounds of excess weight or had stayed ... or currently thin. The participants were then asked about ...
... 13 for SLEEP 2012, the premier event for sleep ... with the best clinical practices. SLEEP 2012, the 26th ... is being held at the John B. Hynes Veterans Memorial ... exhibition hall focused solely on sleep medicine and sleep research. ...
... HealthDay Reporter , TUESDAY, May 29 (HealthDay News) ... medicine cabinet staples such as aspirin, Motrin and Aleve ... several major forms of skin cancer, a new Danish ... of both prescription and nonprescription NSAIDs on skin cancer ...
... A specific antioxidant supplement may be an effective ... pilot trial from the Stanford University School of Medicine ... with the disorder. The antioxidant, called N-Acetylcysteine, or ... as reducing the children,s repetitive behaviors. The researchers emphasized ...
Cached Medicine News:Health News:Hear to see: New method for the treatment of visual field defects 2Health News:Optimism, Laughter May Bring Long Life 2Health News:Optimism, Laughter May Bring Long Life 3Health News:Once-Obese Women Still Face Stigma, Study Finds 2Health News:SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston 2Health News:Common Painkillers May Help Prevent Skin Cancer: Study 2Health News:Common Painkillers May Help Prevent Skin Cancer: Study 3Health News:Antioxidant shows promise as treatment for certain features of autism, Stanford study finds 2Health News:Antioxidant shows promise as treatment for certain features of autism, Stanford study finds 3
Trio is a portable pipette stand that keeps your Gilson pipettes within easy reach. A great accessory for use in a fume hood....
Inquire...
... Software is easy to ... with any balance. Use the standard method ... weighings, volume, temperature, pressure, etc.) QualiTrace automatically ... of the measurements from the balance to ...
Reservoir, Low Profile, Single Well, Flat Bottom, 90mL Available Sterile...
Medicine Products: